David C. Benedicto

Principal Accounting Officer, Adamis Pharmaceuticals Corporation.

Companies

Adamis Pharmaceuticals CorporationChief financial officer Dec 3, 2021 to Mar 22, 2022¹
Adamis Pharmaceuticals CorporationPrincipal Accounting Officer Jun 2, 2021 to Jun 2, 2021²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Adamis Pharmaceuticals Corporation ADMP39,875 shares³Mar 18, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 18, 2022Sold 3,603 shares at $0.61 of Adamis Pharmaceuticals Corporation³
Dec 1, 2021Sold 13,554 shares at $0.79 of Adamis Pharmaceuticals Corporation⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAdamis Pharmaceuticals Corporation, Chief financial officer
2
SEC EDGARAdamis Pharmaceuticals Corporation, Principal Accounting Officer
3
SEC EDGARAdamis Pharmaceuticals Corporation shares after the filing of Mar 18, 2022
4
SEC EDGARForm 4 filed Dec 3, 2021